Results

Total Results: 489 records

Showing results for "psa".
Users also searched for: aspirin

81. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
    March 29, 2013 - The PSA test is used to measure blood levels of PSA, a protein produced by the prostate gland. 4 Elevated … X=unknown I T1a–c N0 M0 PSA<10 Gleason ≤6   T2a N0 M0 PSA<10 Gleason ≤6   … T1–2a N0 M0 PSA X Gleason X IIA T1a–c N0 M0 PSA<20 Gleason 7   T1a–c N0 … M0 PSA≥10<20 Gleason ≤6   T2a N0 M0 PSA≥10<20 Gleason ≤6   T2a N0 M0 PSA<20 … T2c N0 M0 Any PSA Any Gleason   T1–2 N0 M0 PSA ≥20 Any Gleason   T1–2 N0

82. Prostate-Cancer-Therapies-Update Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
    April 01, 2013 - The PSA test is used to measure blood levels of PSA, a protein produced by the prostate gland.4 Elevated … Anatomic and prognostic staging Stage Group T* N M PSA Gleason I T1a–c N0 M0 PSA<10 Gleason ≤6 T2a … N0 M0 PSA<10 Gleason ≤6 T1–2a N0 M0 PSA X Gleason X IIA T1a–c N0 M0 PSA<20 Gleason 7 T1a–c N0 M0 … PSA≥10<20 Gleason ≤6 T2a N0 M0 PSA≥10<20 Gleason ≤6 T2a N0 M0 PSA<20 Gleason 7 T2b N0 M0 PSA<20 … Gleason ≤7 IIB T2b N0 M0 PSA X Gleason X T2c N0 M0 Any PSA Any Gleason T1–2 N0 M0 PSA≥20 Any Gleason

83. Prostate-Cancer-Therapies-Update Research-Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
    April 01, 2013 - The PSA test is used to measure blood levels of PSA, a protein produced by the prostate gland.4 Elevated … Anatomic and prognostic staging Stage Group T* N M PSA Gleason I T1a–c N0 M0 PSA<10 Gleason ≤6 T2a … N0 M0 PSA<10 Gleason ≤6 T1–2a N0 M0 PSA X Gleason X IIA T1a–c N0 M0 PSA<20 Gleason 7 T1a–c N0 M0 … PSA≥10<20 Gleason ≤6 T2a N0 M0 PSA≥10<20 Gleason ≤6 T2a N0 M0 PSA<20 Gleason 7 T2b N0 M0 PSA<20 … Gleason ≤7 IIB T2b N0 M0 PSA X Gleason X T2c N0 M0 Any PSA Any Gleason T1–2 N0 M0 PSA≥20 Any Gleason

84. STATISTICAL BRIEF #82: Access to Care and Use of Preventive Services, 2002: Estimates for the U.S. Civilian Noninstitutionalized Population, Age 18 to 64
    meps.ahrq.gov/data_files/publications/st82/stat82.shtml
    June 01, 2005 - with private health insurance were more likely (58.7 percent) to obtain a prostate-specific antigen (PSA … In comparison, men with no health insurance coverage were the least likely to have a PSA test. … In 2002, only 22.2 percent of uninsured men had a PSA test within the last year, and 28.5 percent had … Among men with only public health insurance, 33.9 percent had a PSA test within the last year and 45.4 … Mammogram screening, Pap test, and PSA test were included in this analysis.

85. Sb82
    meps.ahrq.gov/data_files/publications/st82/sb82.xml
    June 01, 2005 - with private health insurance were more likely (58.7 percent) to obtain a prostate-specific antigen (PSA … In comparison, men with no health insurance coverage were the least likely to have a PSA test. … In 2002, only 22.2 percent of uninsured men had a PSA test within the last year, and 28.5 percent had … Among men with only public health insurance, 33.9 percent had a PSA test within the last year and 45.4 … Mammogram screening, Pap test, and PSA test were included in this analysis.

86. Statistical Brief #82: Access to Care and Use of Preventive Services, 2002: Estimates for the U.S. Civilian Noninstitutionalized Population, Age 18 to 64 (pdf file)
    meps.ahrq.gov/data_files/publications/st82/stat82.pdf
    June 01, 2005 - private health insurance were more likely (58.7 percent) to obtain a prostate-specific antigen (PSA … to 64 covered by private health insurance were more likely to obtain a prostate-specific antigen (PSA … In comparison, men with no health insurance coverage were the least likely to have a PSA test. … In 2002, only 22.2 percent of uninsured men had a PSA test within the last year, and 28.5 percent had … Mammogram screening, Pap test, and PSA test were included in this analysis.

87. STATISTICAL BRIEF #82: Access to Care and Use of Preventive Services, 2002: Estimates for the U.S. Civilian Noninstitutionalized Population, Age 18 to 64
    meps.ahrq.gov/data_files/publications/st82/draft/stat82.shtml
    June 01, 2005 - with private health insurance were more likely (58.7 percent) to obtain a prostate-specific antigen (PSA … In comparison, men with no health insurance coverage were the least likely to have a PSA test. … In 2002, only 22.2 percent of uninsured men had a PSA test within the last year, and 28.5 percent had … Among men with only public health insurance, 33.9 percent had a PSA test within the last year and 45.4 … Mammogram screening, Pap test, and PSA test were included in this analysis.

88. Renal Failure Due to Benign Prostatic Hyperplasia | PSNet
    psnet.ahrq.gov/web-mm/renal-failure-due-benign-prostatic-hyperplasia
    February 01, 2004 - , the patient was seen by a physician assistant who inquired about prior prostate specific antigen (PSA … According to the patient, when he answered that he had never had PSA testing, he was berated for not … work including a PSA test, scheduled a cystoscopy, and urged the patient to self-catheterize should … A PSA test is often ordered in this clinical situation but should not be performed without discussing … , PSA levels decrease about 50% on a 5-ARI, and a subsequent increase in an adherent patient may warn

89. U.S. Preventive Services Task Force Issues Final Recommendation on Screening for Prostate Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/prostate-cancer-news-bulletin-updated-102018.pdf
    May 08, 2018 - patients with important new information about the benefits and harms of prostate-specific antigen (PSA … the Task Force recommends that men ages 55 to 69 make an individual decision about whether to get PSA-based … The PSA test measures the amount of prostate-specific antigen, a type of protein, in a man’s blood. … An elevated PSA level may be caused by prostate cancer, but it could also be caused by other conditions … PSA-based screening and the prostate biopsies used to follow-up on high PSA levels cannot tell for sure

90. Comparative Effectiveness of Drug Therapy for Psoriatic Arthritis in Adults – An Update to the 2007 Report | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research-protocol
    December 01, 2019 - PsA has a highly variable presentation, which generally involves pain and inflammation in joints and … Additionally, PsA may predate the development of skin disease leading to some diagnostic uncertainty. … In the general population the prevalence of PsA is estimated to be 0.3% to 1%. … Treatment of psoriatic arthritis (PsA) aims to control pain and inflammation and, ultimately, to slow … The oral DMARDs used to treat patients with PsA are hydrochloroquine, leflunomide, methotrexate, and

91. Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research
    December 01, 2019 - oral and biologic disease-modifying antirheumatic drugs (DMARDs) for adults with psoriatic arthritis (PsA … controlled trials meeting inclusion criteria existed for any drugs in this review for treating patients with PsA … evidence supported the efficacy of adalimumab, etanercept, golimumab, and infliximab for the treatment of PsA … conclusions on comparative efficacy, effectiveness, and harms of either oral or biologic DMARDs for PsA … therapy to prevent or minimize debilitating joint damage and optimize quality of life for people with PsA

92. Treating Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/consumer
    November 01, 2020 - PSA blood test: This blood test tells how much PSA (a protein made by the prostate gland) is in your … Many men with prostate cancer have PSA levels that are higher than normal or that have gotten higher … A high PSA level does not always mean a man has prostate cancer. … This growth, and other health conditions, can cause a high PSA level in men who do not have prostate … During checkups, your doctor may do a digital rectal exam, a PSA blood test, a biopsy, or other tests

93. Clinical Summary: Screening for Prostate Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/D2Y537H2WCXLrT82Z2M46u
    April 30, 2018 - Screening for prostate cancer begins with a test that measures the amount of prostate-specific antigen (PSA … An elevated PSA level may be caused by prostate cancer but can also be caused by other conditions, including … Men with a positive PSA test result may undergo a transrectal ultrasound-guided core-needle biopsy of

94. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/clinician
    January 21, 2016 - Presenting symptoms, a physical examination, a prostate-specific antigen (PSA) test, and a biopsy may … convened in 2011 recommended that AS—a strategy with curative intent that involves regular monitoring of PSA … and then intervening to manage them. 3 WW does not include active monitoring such as performing a PSA … Physicians might take into consideration age, general health status, stage of tumor, PSA level, Gleason … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations.

95. Measures of Inefficiency | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/chartbooks/careaffordability/measures3.html
    June 01, 2018 - Services Task Force recommended against screening men age 75 and over with prostate-specific antigen (PSA … Overall Rate: In 2014, 21.1% of men age 40 and over reported a PSA test in the past year (data not shown … Groups With Disparities: In 2014, men ages 40-54 were less likely to receive a PSA test in the past … Among men ages 40-54, Asians were less likely than Whites to receive PSA testing and Blacks were more … Among men age 75 and over, AI/ANs were less likely than Whites to receive PSA testing.

96. Narrator V/O: (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/publications/pubcomguide/PSA-Video-Script-Sample.doc
    June 10, 2024 - Narrator V/O: PSA DISCOVERY HEALTH & AHRQ “Understanding Your Prescription” – · :30 Version 2 Narrator

97. Narrator V/O: (doc file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/publications/pubcomguide/PSA-Audio-Script-Sample.doc
    June 10, 2024 - Narrator V/O: AUDIO PSA :30 AHRQ (8/13/07) TIPS WHEN GETTING MEDICAL TESTS  Asking Questions Consumer

98. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - About 50% of patients with PsA have the HLA-B27 allele. … The main symptoms of PsA are joint pain, stiffness, and swelling that can affect any joint. … Secukinumab (Cosentyx) for Treatment of Psoriatic Arthritis  Key Facts: Current treatments for PsA … By blocking the effects of IL-17A–localized autoimmune reactions, PsA symptoms may be limited while … Four phase III trials on secukinumab for treating PsA are ongoing.

99. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - About 50% of patients with PsA have the HLA-B27 allele. … The main symptoms of PsA are joint pain, stiffness, and swelling that can affect any joint. … Secukinumab (Cosentyx) for Treatment of Psoriatic Arthritis  Key Facts: Current treatments for PsA … By blocking the effects of IL-17A–localized autoimmune reactions, PsA symptoms may be limited while … Four phase III trials on secukinumab for treating PsA are ongoing.

100. Prostate-Specific Antigen–Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/b-rsH7WPpNC3uL9NeoXBfF
     May 08, 2018 - OBJECTIVE To systematically review evidence on prostate-specific antigen (PSA)–based prostate cancer … Randomization to PSA screening was not associated with reduced risk of prostate cancer mortality in either … 2 What are the harms of PSA-based screening for prostate cancer and diagnostic follow-up? a. … Effectiveness of PSA-Based Screening Key Question 1. … What are the harms of PSA-based screening for pros- tate cancer and diagnostic follow-up?